Korobko I V, Georgiev P G, Skryabin K G, Kirpichnikov M P
Institute of Gene Biology RAS, Vavilova Str. 34/5, 119334, Moscow, Russia.
The Federal Research Centre "Fundamentals of Biotechnology" RAS, Leninskii prospect Str. 33, build. 2, 119071, Moscow, Russia.
Acta Naturae. 2016 Oct-Dec;8(4):6-13.
Russian legislation lags behind the rapid developments witnessed in genetic engineering. Only a scientifically based and well-substantiated policy on the place of organisms that are created with the use of genetic engineering technologies and an assessment of the risks associated with them could guarantee that the breakthroughs achieved in modern genetic engineering technologies are effectively put to use in the real economy. A lack of demand for such breakthroughs in the practical field will lead to stagnation in scientific research and to a loss of expertise.
俄罗斯的立法落后于基因工程领域所见证的快速发展。只有一项基于科学且有充分依据的政策，来规范利用基因工程技术创造的生物体的地位，并对与之相关的风险进行评估，才能确保现代基因工程技术所取得的突破在实体经济中得到有效应用。实际领域对这类突破缺乏需求将导致科研停滞和专业知识的流失。
